1-3 of 3
Mario Carotenuto
Close
Sort by
Journal Articles

A prospective study of residual-disease monitoring of the ALL1/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia

Giuseppe Cimino, Loredana Elia, Maria Cristina Rapanotti, Teresa Sprovieri, Marco Mancini, Antonio Cuneo, Cristina Mecucci, Giuseppe Fioritoni, Mario Carotenuto, Enrica Morra, Vincenzo Liso, Luciana Annino, Giuseppe Saglio, Giulio De Rossi, Robin Foà, Franco Mandelli
Journal: Blood
Blood (2000) 95 (1): 96–101.
https://doi.org/10.1182/blood.V95.1.96
Published: 2000
Journal Articles

Serum Level of the Soluble Form of the CD30 Molecule Identifies Patients With Hodgkin's Disease at High Risk of Unfavorable Outcome

Gianpaolo Nadali, Luisa Tavecchia, Elisabetta Zanolin, Valeria Bonfante, Simonetta Viviani, Edgarda Camerini, Pellegrino Musto, Nicola Di Renzo, Mario Carotenuto, Marco Chilosi, Mauro Krampera, Giovanni Pizzolo
Journal: Blood
Blood (1998) 91 (8): 3011–3016.
https://doi.org/10.1182/blood.V91.8.3011.3011_3011_3016
Published: 1998
Journal Articles

Long-Term Results From MOPPEBVCAD Chemotherapy With Optional Limited Radiotherapy in Advanced Hodgkin's Disease

Paolo G. Gobbi, Carla Pieresca, Maria L. Ghirardelli, Nicola DiRenzo, Massimo Federico, Francesco Merli, Emilio Iannitto, Vincenzo Pitini, Giovanni Grignani, Amedea Donelli, Mario Carotenuto, Vittorio Silingardi, Edoardo Ascari, the Gruppo Italiano per lo Studio dei Linfomi
Journal: Blood
Blood (1998) 91 (8): 2704–2712.
https://doi.org/10.1182/blood.V91.8.2704.2704_2704_2712
Published: 1998